Recombinant Human SLURP2 Protein (Yeast)，His

SLURP2, a member of the Ly6/uPAR protein family, has gained attention in recent years due to its diverse biological functions and potential implications in human health and disease. Initially discovered in the context of the skin's immune response, SLURP2 is mainly expressed in epithelial tissues, including the skin and mucosal surfaces. Research has revealed that SLURP2 plays a critical role in modulating inflammatory responses, and it has been implicated in autoimmune diseases, particularly in conditions like psoriasis, where its expression levels are altered. Additionally, SLURP2 exhibits antimicrobial properties, suggesting a function in innate immunity. Its interaction with nicotinic acetylcholine receptors has also been explored, linking it to neurobiological effects and potential therapeutic avenues in treating neurodegenerative diseases. As a result, a growing body of research focuses on characterizing its structure and function, with recombinant SLURP2 proteins being produced for detailed functional studies. This ongoing research aims to clarify SLURP2's mechanisms of action, explore its potential as a biomarker for disease, and identify possible therapeutic applications, underscoring its significance in both fundamental biology and clinical applications. Through these studies, SLURP2 is positioned as a promising candidate for future biomedical research, contributing to our understanding of immune regulation and potential treatments for related conditions.